> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Glucotrol Not Withdrawn Due to Safety/Efficacy: FDA
- URL: https://www.fdaweb.com/glucotrol-not-withdrawn-due-to-safety-efficacy-fda/
- Published: 2022-05-10T12:00:00.000Z
- Updated: 2026-09-14T17:44:05.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5151779

*Federal Register* notice: FDA has determined that Pfizer’s Glucotrol (glipizide) tablets, 2.5 mg, were not withdrawn from sale due to safety or effectiveness reasons. The determination will allow the agency to approve ANDAs that reference the product if all other legal and regulatory requirements are met. Glucotrol is indicated as an adjunct to diet and exercise to improve glycemic control in adults with Type 2 diabetes mellitus. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2022-05-10/pdf/2022-09944.pdf?ref=fdaweb.com).